Anbenitamab plus HB1801 for HER2-Positive Advanced Breast Cancer
Original Article
J. Wang, H. Li, F. Xu, T. Wu, Z. Tong, J. Cui, X. Wang, Z. Song, T. Sun, H. Li, W. Xie, J. Sun, X. Zhang, Y. Teng, X. Li, J. Zhu, T. Luo, B. Zhao, F. Ning, C. Xie, L. Gan, G. Yin, Y. Li, C. Yuan, W. You, Z. Wu, Q. Liu, X. Kong, J. Chang, J. Zhao, Z. Zhai, Q. Ouyang, X. Han, F. Li, J. Nie, G. Han, C. Xia, W. Huang, S. Xiang, K. Zou, Y. Wang, and B. Xu
N Engl J Med 2026;395:1981-1992
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
11/18/2026
Course expires:
11/19/2028
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward